Alticor Inc., 10% Owner at INTERLEUKIN GENETICS INC (ILI), bought 2,750,037 shares at $5.68 ($15.6M) on 2006-08-17, disclosed to the SEC on 2006-08-21.
Open-market purchase of $15.6M ILI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.